JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, cilt.40, sa.3, ss.797-805, 2014 (SCI-Expanded)
AimTo evaluate the long-term oncological and reproductive outcomes of patients aged 25 years and younger who were treated by fertility-sparing cytoreductive surgery (FSCS) plus adjuvant chemotherapy (ACT) or observation alone for malignant ovarian germ cell tumors (MOGCT).